Your browser doesn't support javascript.
Implications of COVID-19 on Time-Sensitive STEMI Care: A Report From a North American Epicenter.
Haddad, Kevin; Potter, Brian J; Matteau, Alexis; Gobeil, François; Mansour, Samer.
  • Haddad K; Faculty of Medicine, Université de Montréal, Montréal, Québec, Canada; Centre Hospitalier de l'Université de Montréal (CHUM) Research Center, Montréal, Québec, Canada.
  • Potter BJ; Faculty of Medicine, Université de Montréal, Montréal, Québec, Canada; Centre Hospitalier de l'Université de Montréal (CHUM) Research Center, Montréal, Québec, Canada.
  • Matteau A; Faculty of Medicine, Université de Montréal, Montréal, Québec, Canada; Centre Hospitalier de l'Université de Montréal (CHUM) Research Center, Montréal, Québec, Canada.
  • Gobeil F; Faculty of Medicine, Université de Montréal, Montréal, Québec, Canada; Centre Hospitalier de l'Université de Montréal (CHUM) Research Center, Montréal, Québec, Canada; Cité-de-la-Santé Hospital, Laval, Québec, Canada.
  • Mansour S; Faculty of Medicine, Université de Montréal, Montréal, Québec, Canada; Centre Hospitalier de l'Université de Montréal (CHUM) Research Center, Montréal, Québec, Canada; Cité-de-la-Santé Hospital, Laval, Québec, Canada. Electronic address: s.mansour@umontreal.ca.
Cardiovasc Revasc Med ; 30: 33-37, 2021 09.
Article in English | MEDLINE | ID: covidwho-808136
ABSTRACT

BACKGROUND:

Coronavirus disease 2019 (COVID-19) has forced dramatic changes to the healthcare systems throughout the world. Time-sensitive management of cardiovascular emergencies such as ST-elevation myocardial infarction (STEMI) has yet to be evaluated in the context of these new policies, particularly in so-called "hot spot" cities.

METHODS:

We evaluated the early impact of the pandemic on STEMI performance in the Greater Montreal Area. A total of 167 patients from 3 different study periods were included. Patients presenting in the lockdown period from mid-March to mid-May 2020 (Group C, 53 patients) were compared to those from mid-March to mid-May 2019 (Group A, 60 patients) and the 2020 pre-COVID-19 period (Group B, 54 patients).

RESULTS:

The number of STEMI admissions was unaffected during the lockdown. However, significantly longer delays between symptom onset and first medical contact (FMC) were noted (Group C 189.0 IQR [70.0, 840.0] min vs. Group A 103.0 IQR [42.5, 263.0] min vs. Group B 91.0 IQR [38.0, 235.5 min], P = 0.007). In contrast, additional safety protocols do not appear to have significantly affected delays between FMC and first intracoronary device activation (Group C 102 IQR [73.0, 133.0] min vs. Group A 104 IQR [87.0, 146.0] min vs. Group B 99.5 IQR [80.0, 150.0] min, P = 0.37). Patients that presented during the outbreak were more likely to be unstable with a higher incidence of Killip classes II-IV compared to groups A and B (28.3% vs. 18.3% vs. 5.6% respectively, P = 0.008). Worse in-hospital outcomes were also noted with a significantly higher rate of major adverse cardiac events (Group A 5.0% vs. Group B 11.1% vs. Group C 22.6%, P = 0.007).

CONCLUSION:

During the lockdown period, many patients appear to have been reluctant to present to hospitals. This was associated with more unstable STEMI presentations and worse in-hospital course. Importantly, the health care system appears able to ensure timely acute cardiac care while ensuring that COVID-19 protocols are respected.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Percutaneous Coronary Intervention / ST Elevation Myocardial Infarction / COVID-19 Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Humans Country/Region as subject: North America Language: English Journal: Cardiovasc Revasc Med Journal subject: Vascular Diseases / Cardiology Year: 2021 Document Type: Article Affiliation country: J.carrev.2020.09.024

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Percutaneous Coronary Intervention / ST Elevation Myocardial Infarction / COVID-19 Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Humans Country/Region as subject: North America Language: English Journal: Cardiovasc Revasc Med Journal subject: Vascular Diseases / Cardiology Year: 2021 Document Type: Article Affiliation country: J.carrev.2020.09.024